
With $125 million, 'microbubble' startup looks to launch gene therapy trial next year - The Business Journals
The microbubble startup is focused on developing innovative gene therapy solutions. With a significant funding round of $125 million, the company aims to launch a clinical trial next year, marking a pivotal step in its growth and development.
With $125 million, 'microbubble' startup looks to launch gene therapy trial next year The Business Journals
| Jul 02, 2026 | Age Care Labs | $9.0M | Series B | India |
| Jul 01, 2026 | Supply6 | $5.8M | Series A | India |
| Jul 01, 2026 | Mykare.ai | $1.0M | — | India |
| Jun 30, 2026 | Buffalo sleep apnea care startup | $20.0M | — | United States |